S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled

Mind Medicine (MindMed) Stock Price, News & Analysis (OTCMKTS:MMEDF)

$3.30
+0.06 (+1.85%)
(As of 11/30/2023 ET)
Compare
Today's Range
$3.19
▼
$3.36
50-Day Range
$2.43
▼
$3.70
52-Week Range
$0.29
▼
$5.07
Volume
454,655 shs
Average Volume
3.38 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines

MMEDF stock logo

About Mind Medicine (MindMed) Stock (OTCMKTS:MMEDF)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

MMEDF Stock Price History

MMEDF Stock News Headlines

October 26, 2023 | financialpost.com
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update
August 15, 2023 | benzinga.com
MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year
December 1, 2023 | Wealthpress (Ad)
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
August 4, 2023 | msn.com
RBC Capital Maintains Mind Medicine (MNMD) Outperform Recommendation
July 19, 2023 | stockhouse.com
Thinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences?
July 4, 2023 | thestreet.com
Mind Medicine (MindMed), Inc.
June 27, 2023 | msn.com
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 22, 2023 | marketwatch.com
8-K: Mind Medicine (MindMed) Inc.
December 1, 2023 | Tomorrow Investor (Ad)
Why Microsoft Just Placed A Huge Bet On Nuclear
Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.
May 25, 2023 | businesswire.com
MindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and Shareholders
May 5, 2023 | benzinga.com
FCM Releases Letter to Fellow MindMed Shareholders Highlighting Board and Management's Track Record of Shareholder Value Destruction
May 1, 2023 | benzinga.com
MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update
April 26, 2023 | msn.com
MindMed CEO On Latest Positive Topline Phase 2 Data And Freedom Capital Management
November 11, 2022 | benzinga.com
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
October 26, 2022 | msn.com
Mind Medicine (MNMD) to Report Q3 Earnings: What's in Store?
October 4, 2022 | nasdaq.com
Why Mind Medicine Stock Triumphed on Tuesday
September 29, 2022 | nasdaq.com
Why Mind Medicine Stock Soared on a Down Day for the Market
September 29, 2022 | uk.investing.com
Mind Medicine Inc (MNMD)
September 28, 2022 | nasdaq.com
Mind Medicine Stock (NASDAQ:MNMD): Investors Just Got a Dose of Reality
September 28, 2022 | msn.com
Stock of psychedelics company MindMed slides 50% after it sells fresh shares
September 28, 2022 | msn.com
Why MindMed Stock Is Tanking Today
September 27, 2022 | benzinga.com
MindMed Announces Proposed Public Offering of Common Shares
September 15, 2022 | finance.yahoo.com
MindMed to Participate in H.C. Wainwright Global Investment Conference
September 9, 2022 | msn.com
Mind Medicine shares up as Phase 2b studies continue on medical LSD
September 8, 2022 | msn.com
Why Mind Medicine (MindMed) Stock Tumbled This Week
September 4, 2022 | seekingalpha.com
MindMed: Confusing MEME Rally Hides A Company That Looks Empty Of Value
August 30, 2022 | finance.yahoo.com
Wall Street Analysts Predict a 399% Upside in Mind Medicine MindMed Inc. (MNMD): Here's What You Should Know
See More Headlines
Receive MMEDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MMEDF
CUSIP
N/A
CIK
N/A
Web
www.mindmed.co
Phone
N/A
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Jamon Alexander Rahn
    Co-Founder, CEO & Director
  • Dr. Miriam Halperin Wernli
    Exec. Pres & Director
  • Dr. Scott M. Freeman (Age 64)
    Co-Founder & Clinical Advisor
  • Mr. Leonard Latchman
    Co-founder
  • Mr. David Dean Guebert
    Chief Financial Officer
  • Ms. Carol Nast
    Chief Operating Officer
  • Mr. Bradford Cross
    Chief Technology Officer
  • Dr. Donald R. Gehlert Ph.D.
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Ms. Madeline Feldman
    Director of Operations & Admin.
  • Mr. Collin Gage
    VP of Corp. Devel.

Key Competitors

View All Competitors














MMEDF Stock Analysis - Frequently Asked Questions

How have MMEDF shares performed in 2023?

Mind Medicine (MindMed)'s stock was trading at $2.20 at the beginning of 2023. Since then, MMEDF stock has increased by 50.0% and is now trading at $3.30.
View the best growth stocks for 2023 here.

How do I buy shares of Mind Medicine (MindMed)?

Shares of MMEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:MMEDF) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -